A Double-Blind, Dose-Response Study of the Efficacy and Safety of Olmesartan Medoxomil in Children and Adolescents with Hypertension-Reference-Cited by-同舟云学术

A Double-Blind, Dose-Response Study of the Efficacy and Safety of Olmesartan Medoxomil in Children and Adolescents with Hypertension

Published:2010-06 Issue:6 Volume:55 Page:1323-1330
ISSN:0194-911X
Container-title:Hypertension
language:en
Short-container-title:Hypertension

Author:

Hazan Lydie¹,Hernández Rodriguez Oscar A.¹,Bhorat As'ad E.¹,Miyazaki Koichi¹,Tao Ben¹,Heyrman Reinilde¹

Affiliation:

1. From Impact Clinical Trials (L.H.), Los Angeles, Calif; Instituto Nacional del Riñon (O.A.H.R.), Bogotá, Colombia; 1900 Diamimi Ext 2 (A.E.B.), Soweto, Gauteng, South Africa; Daiichi Sankyo, Inc. (K.M., B.T., R.H.), Parsippany, NJ.

Publisher

Ovid Technologies (Wolters Kluwer Health)

Subject

Internal Medicine

Reference15 articles.

1. The Fourth Report on the Diagnosis, Evaluation, and Treatment of High Blood Pressure in Children and Adolescents

2. Seventh Report of the Joint National Committee on Prevention, Detection, Evaluation, and Treatment of High Blood Pressure

3. Overweight, Ethnicity, and the Prevalence of Hypertension in School-Aged Children

4. Blood Pressure in Children With Chronic Kidney Disease

5. Families and the natural history of blood pressureA 27-year follow-up study

Cited by 63 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Efficacy and Safety of Angiotensin Receptor Blockers in Pediatric Patients (Aged 6 to 18) with Hypertension: A Systematic Review;IRAN J KIDNEY DIS;2023

2. Changes in Drug Development Regulations and Their Impact on Clinical Trials;Pediatric Hypertension;2023

3. Pharmacologic Treatment of Pediatric Hypertension;Pediatric Hypertension;2023

4. Narrative update of clinical trials with antihypertensive drugs in children and adolescents;Frontiers in Cardiovascular Medicine;2022-11-21

5. Functional Significance of Cardiac Rehabilitation-Regulated Expression of Circulating MicroRNA-423-5p in Hypertensive Patients with Heart Failure with a Moderately Reduced Ejection Fraction;The Anatolian Journal of Cardiology;2022-05-10